Affiliation:
1. Infectious Diseases Service
2. Microbiology Service
3. Pharmacy Service, Hospital Universitari de Bellvitge, Feixa Llarga, sn., L'Hospitalet de Llobregat, 08907 Barcelona, Spain
Abstract
ABSTRACT
Enterobacter cloacae
has been associated with several outbreaks, usually involving strains that overproduce chromosomal β-lactamase or, uncommonly, strains expressing extended-spectrum β-lactamases (ESBL). Only sporadic cases of ESBL-producing
E. cloacae
have been identified in our hospital in recent years. We describe the epidemiology and clinical and microbiological characteristics of an outbreak caused by ESBL-producing
E. cloacae
in a cardiothoracic intensive care unit (CT-ICU). Prospective surveillance of patients with infection or colonization by ESBL-producing
E. cloacae
among patients admitted to the CT-ICU was performed during the outbreak. Production of ESBL was determined by decreased susceptibility to expanded-spectrum cephalosporins and a positive double-disk test result. Clone relatedness was determined by pulsed-field gel electrophoresis (PFGE). From July to September 2005, seven patients in the CT-ICU with ESBL-producing
E. cloacae
were identified (four males; median age, 73 years; range, 45 to 76 years); six patients had cardiac surgery. Four patients developed infections; three had primary bacteremia, one had ventilator-associated pneumonia, and one had tracheobronchitis. ESBL-producing
E. cloacae
showed resistance to quinolones and aminoglycosides. PFGE revealed two patterns. Five isolates belonged to clone A; two carried a single ESBL (pI 8.2 and a positive PCR result for the SHV type), and three carried two ESBLs (pIs 8.1 and 8.2 and positive PCR results for the SHV and CTX-M-9 types). Isolates belonging to clone B carried a single ESBL (pI 5.4 and a positive PCR result for the TEM type). Review of antibiotic consumption showed increased use of cefepime and quinolones during June and July 2005. The outbreak was stopped by the implementation of barrier measures and cephalosporin restriction. ESBL production could be increasingly common in nosocomial pathogens other than
Escherichia coli
or
Klebsiella pneumoniae
.
Publisher
American Society for Microbiology
Reference36 articles.
1. Prevalence of Extended-Spectrum β-Lactamase-Producing
Enterobacter cloacae
in the Asia-Pacific Region: Results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001
2. Brahmi, N., Y. Blel, N. Kouraichi, S. Lahdhiri, H. Thabet, A. Hedhili, and M. Amamou. 2006. Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit. J. Infect. Chemother.12:190-194.
3. Cantón, R., A. Oliver, M. T. Coque, C. Varela, J. C. Perez-Díaz, and F. Baquero. 2002. Epidemiology of extended-spectrum β-lactamase-producing Enterobacter cloacae isolates in a Spanish hospital during a 12-year period. J. Clin. Microbiol.40:237-1243.
4. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. 2006
5. Conte, M. P., M. Venditti, F. Chiarini, G. D'Ettorre, I. Zamboni, G. L. Scoarughi, C. Gallinelli, and G. B. Orsi. 2005. Extended spectrum beta-lactamase-producing Klebsiella pneumoniae outbreaks during a third generation cephalosporin restriction policy. J. Chemother.17:66-73.
Cited by
46 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献